Trinity Capital downgraded by Keefe Bruyette with a new price target
$TRIN
Finance: Consumer Services
Finance
Keefe Bruyette downgraded Trinity Capital from Outperform to Mkt Perform and set a new price target of $12.50 from $16.00 previously
Save time and jump to the most important pieces.
| Date | Price Target | Rating | Analyst |
|---|---|---|---|
| 8/22/2023 | $15.50 | Neutral → Buy | Compass Point |
| 8/7/2023 | $15.00 | Underperform → Mkt Perform | Keefe Bruyette |
| 7/5/2023 | $15.00 | Buy | Jefferies |
| 3/13/2023 | $13.50 → $11.00 | Mkt Perform → Underperform | Keefe Bruyette |
| 11/7/2022 | $30.00 | Positive → Neutral | Susquehanna |
| 11/4/2022 | $16.00 → $12.50 | Outperform → Mkt Perform | Keefe Bruyette |
| 10/27/2022 | $18.00 → $12.75 | Buy → Neutral | Compass Point |
| 9/16/2022 | $14.50 | Buy | B. Riley Securities |
Compass Point upgraded Trinity Capital from Neutral to Buy and set a new price target of $15.50
Keefe Bruyette upgraded Trinity Capital from Underperform to Mkt Perform and set a new price target of $15.00
Jefferies initiated coverage of Trinity Capital with a rating of Buy and set a new price target of $15.00
Trinity Capital Inc. (NASDAQ:TRIN) ("Trinity"), a leading provider of diversified financial solutions to growth-oriented companies, today announced the commitment of $15 million in growth capital to Velentium, a professional engineering firm that specializes in the design and manufacture of innovative medical devices.Based in Houston, Velentium designs, develops, manufactures, and provides post-market support for medical devices, particularly active implantable and wearable devices. With expertise in systems engineering, software, cybersecurity, mobile/cloud solutions, and automated test systems, Velentium collaborates with clients worldwide to create medical solutions that improve lives.
4 - Trinity Capital Inc. (0001786108) (Issuer)
4 - Trinity Capital Inc. (0001786108) (Issuer)
4 - Trinity Capital Inc. (0001786108) (Issuer)
8-K - Trinity Capital Inc. (0001786108) (Filer)
10-Q - Trinity Capital Inc. (0001786108) (Filer)
8-K - Trinity Capital Inc. (0001786108) (Filer)
PHOENIX, July 22, 2024 /PRNewswire/ -- Trinity Capital Inc. (NASDAQ:TRIN) ("Trinity" or the "Company"), a leading provider of diversified financial solutions to growth-oriented companies, today announced the appointment of Josh Ruben as Managing Director of Life Sciences. Mr. Ruben, an established leader with over a decade of experience in investment banking, has a long track record of supporting life science companies with over $50 billion of transactions completed across M&A and capital raises. He is based in Phoenix, AZ. "We are delighted to welcome Josh to our team," said
Appoints Craig Fox to Lead New Venture PHOENIX, May 22, 2024 /PRNewswire/ -- Trinity Capital Inc. (NASDAQ:TRIN) ("Trinity" or the "Company"), a leading provider of diversified financial solutions to growth-oriented companies, today announced its strategic expansion into Europe with the appointment of London-based Craig Fox as Managing Director. This initiative aligns with the Company's long-term vision of supporting high-growth companies globally. By establishing a dedicated European team, Trinity aims to capitalize on the growing momentum and venture capital activity in the r
New business to provide growth capital for private-equity-backed companies PHOENIX, May 7, 2024 /PRNewswire/ -- Trinity Capital Inc. (NASDAQ:TRIN) ("Trinity" or the "Company"), a leading provider of diversified financial solutions to growth-oriented companies, today announced the expansion of its business with the addition of a new Sponsor Finance vertical. This strategic expansion naturally extends the Company's established expertise in providing direct lending solutions to sponsor-backed companies across a range of industries. "We see the ability to leverage our market knowl
PHOENIX, Nov. 7, 2024 /PRNewswire/ -- Trinity Capital Inc. (NASDAQ:TRIN) ("Trinity" or the "Company"), a leading provider of diversified financial solutions to growth-oriented companies, today announced that its board of directors has authorized a program for the purpose of repurchasing up to $30 million worth of the Company's common stock. Under the repurchase program, Trinity may, but is not obligated to, repurchase its outstanding common stock in the open market from time to time, provided that Trinity complies with applicable policies and laws, including certain price, mar
Return on average equity of 16.2% NII climbs to a record of $29.4 million, or $0.54 per share Total investment income grows 33% year-over-year PHOENIX, Oct. 30, 2024 /PRNewswire/ -- Trinity Capital Inc. (NASDAQ:TRIN) ("Trinity" or the "Company"), a leading provider of diversified financial solutions to growth-oriented companies, today announced its financial results for the third quarter ended September 30, 2024. Third Quarter 2024 Highlights Record total investment income of $61.8 million, an increase of 33.2% year-over-yearRecord net investment income ("NII") of $29.4 milli
PHOENIX, Oct. 30, 2024 /PRNewswire/ -- Trinity Capital Inc. (NASDAQ:TRIN) ("Trinity" or the "Company"), a leading provider of diversified financial solutions to growth-oriented companies, today announced it has closed a private notes offering totaling $142.5 million in aggregate principal amount of unsecured Series A Notes (as defined below). "We are pleased by this transaction being oversubscribed from the launch amount of $100 million," said Kyle Brown, Chief Executive Officer of Trinity Capital. "This additional capital positions us for continued growth, reinforcing our com
4 - Trinity Capital Inc. (0001786108) (Issuer)
4 - Trinity Capital Inc. (0001786108) (Issuer)
4 - Trinity Capital Inc. (0001786108) (Issuer)
PHOENIX, Nov. 12, 2024 /PRNewswire/ -- Trinity Capital Inc. (NASDAQ:TRIN) ("Trinity"), a leading provider of diversified financial solutions to growth-oriented companies, today announced the commitment of $40 million in growth capital to Impress, a leading orthodontic chain in Europe, specializing in invisible aligners. Headquartered in Barcelona, Spain, Impress' network of clinics spans multiple European countries and serves over 250,000 patients annually. The company's recent acquisition of DrSmile has further solidified its leadership in key European markets. "We're excited
PHOENIX, Nov. 7, 2024 /PRNewswire/ -- Trinity Capital Inc. (NASDAQ:TRIN) ("Trinity" or the "Company"), a leading provider of diversified financial solutions to growth-oriented companies, today announced that its board of directors has authorized a program for the purpose of repurchasing up to $30 million worth of the Company's common stock. Under the repurchase program, Trinity may, but is not obligated to, repurchase its outstanding common stock in the open market from time to time, provided that Trinity complies with applicable policies and laws, including certain price, mar
Return on average equity of 16.2% NII climbs to a record of $29.4 million, or $0.54 per share Total investment income grows 33% year-over-year PHOENIX, Oct. 30, 2024 /PRNewswire/ -- Trinity Capital Inc. (NASDAQ:TRIN) ("Trinity" or the "Company"), a leading provider of diversified financial solutions to growth-oriented companies, today announced its financial results for the third quarter ended September 30, 2024. Third Quarter 2024 Highlights Record total investment income of $61.8 million, an increase of 33.2% year-over-yearRecord net investment income ("NII") of $29.4 milli